Concepedia

William Petkun

WP

4

Publications

1.5K

Citations

4

H-Index

1983

Active since

Affiliations

Pfizer (United States)(Current)

University of Birmingham

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (United States)

William Petkun is an author at Pfizer (United States) specializing in geriatrics, patient safety, and sepsis.

Top concepts

Publications per year

1983–2018

4

Publications

4

Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population

Susan Colilla, Ann Crow, William Petkun et al. · The American Journal of Cardiology · 2013 · 1.3K citations

, , +10

Pneumococcal Bacteremia in Adults

Martin S. Finkelstein, William Petkun, Michael L. Freedman et al. · Journal of the American Geriatrics Society · 1983 · 148 citations

, , +13

Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban

Ping G. Tepper, Jack Mardekian, Cristina Masseria et al. · PLoS ONE · 2018 · 61 citations · Full text

Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial

Michael D. Ezekowitz, Charles V. Pollack, Paul W. Sanders et al. · American Heart Journal · 2016 · 33 citations · Full text

Rows per page

1–4 of 4